PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

2b or NOT to be, page-80

  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    I'm taking it that you told them, but have no response.


    A tonne of other Biotech list IP in their annual report and have much better coverage in intagibles.
    Last edited by Gan_Gans: 01/09/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.